New York A07142 mandates health insurance issuers to ensure at least a majority of prescription drug rebates are passed on to patients at the point.

New York A07142 amends the insurance law and public health law to require health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale. Specifically, enrollees' cost-sharing for prescription drugs must be calculated based on a price reduced by at least 85% of all rebates received. Issuers must submit annual certifications to the superintendent attesting compliance. Rebate information cannot be publicly disclosed to protect financial and competitive interests.

New York A07142 mandates health insurance issuers to ensure at least a majority of prescription drug rebates are passed on to patients at the point.

New York A07142 amends the insurance law and public health law to require health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale. Specifically, enrollees' cost-sharing for prescription drugs must be calculated based on a price reduced by at least 85% of all rebates received. Issuers must submit annual certifications to the superintendent attesting compliance. Rebate information cannot be publicly disclosed to protect financial and competitive interests.